Oregon State University
56
6
13
34
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
8.9%
5 terminated/withdrawn out of 56 trials
87.2%
+0.7% vs industry average
7%
4 trials in Phase 3/4
41%
14 of 34 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (56)
Almonds to Improve Gut Health and Decrease Inflammation
Role: lead
Investigating the Bioavailability of Broccoli Extract Supplements
Role: lead
Discovery of Biological Signatures for Cruciferous Vegetable Intake (Single Serving)
Role: lead
Development and Evaluation CAT and Youth
Role: lead
Opening the Conversation Study
Role: lead
Reducing Pesticide Exposures in Child Care Centers
Role: collaborator
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
Role: lead
Use of Empagliflozin to Treat Prediabetes
Role: lead
Multi-site Animal Assisted Intervention for Children With DD and Their Family Dog
Role: lead
CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)
Role: collaborator
Mindful After Cancer: A Mindfulness-based Therapy Intervention for Sexual Health After Cancer
Role: lead
Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet
Role: lead
Effect of Walnuts on Cognitive Function and Gut Microbiome in Older Adults
Role: lead
Role of Centrum® Silver® in Improving Micronutrient Status in Older Men
Role: lead
An Efficient Treatment for Posttraumatic Injury for Firefighters
Role: collaborator
Ultralow Dose PAH Binary Mixture Study
Role: lead
Benzo[a]Pyrene Ultralow Dose-Response Study
Role: lead
Maternal Stress on Human Milk and Infant Outcomes
Role: collaborator
Shift Worker Intervention for Sleep Health
Role: lead
The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease
Role: lead